FDA Grants Emergency Authorization to Roche’s At-Home COVID-19 Test
FDA Sends Warning Letter to Medtronic About Diabetes Business
FDA Issues Emergency Authorization for Merck’s COVID-19 Treatment
Hackensack Meridian Health Supports Immuno-Oncology Platform
Pharma Execs Site Supply Chain Visibility To Boost Manufacturing
Pfizer to Amend Clinical Study of COVID-19 Vaccine in Children
FDA Approves ViiV Healthcare’s Long-Acting Injectable for HIV
FDA Approves Pfizer’s Drug to Treat Adult Patients With AS
Bristol Myers Squibb Partners for Bispecific T-Cell Candidate
Moderna’s COVID-19 Vaccine Booster Protects Against Omicron
Kite’s Yescarta Helps High-Risk Large B-Cell Lymphoma Patients
J&J’s CAR T-Cell Therapy Effective in Multiple Myeloma Patients
Pfizer to Acquire Arena to Boost Chronic Disease Management
CHMP Issues Positive Opinion of J&J’s COVID-19 Vaccine Booster
Roche Launches Platform to Advance Next-Generation Sequencing
J&J’s COVID-19 Vaccine Booster Increased Antibody, T-Cell Responses
AstraZeneca Enters Agreement for Transthyretin Amyloidosis Medicine
SAGE, WHO Support Johnson & Johnson COVID-19 Vaccine Booster
Moderna Launches Artificial Intelligence Academy for mRNA Therapies
GSK Welcomes Gavi Decision to Fund Routine Malaria Vaccines for Kids
Roche, TIB Molbiol Develop More COVID-19 Tests To Identify Variant
3 Doses of Pfizer’s COVID-19 Vaccine Neutralizes Omicron Variant
GSK, University of Oxford to Uncover Mechanisms of Disease
Thermo Fisher Introduces Protein To Advance CRISPR Gene Editing
GSK Initiative Addresses Key Challenges In Multiple Myeloma Care
FDA Approves Imaging Drug to Identify Ovarian Cancer
AstraZeneca Unveils $1B Research Facility To Advance Gene-Editing
J&J Considers Licensing COVID-19 Vaccine to South African Company
CVS Health Initiatives Increase Affordability, Access To Medicine
Specialty Drugs Accounted for Half of Medicaid Spending in 2020
Pfizer, AWS Collaborate To Improve Drug Development, Manufacturing
FDA Addresses Impacts of New Variant, Urges COVID-19 Vaccinations
Novo Nordisk Enters Pharma Acquisition Deal For RNAi Therapies
Moderna Doses First Patients in Phase 2 Study of mRNA RSV Vaccine
Johnson & Johnson Evaluates COVID-19 Vaccine Against New Variant
GSK Appoints Phil Dormitzer Global Head of Vaccines, Research
Pfizer Confirms COVID-19 Vaccine Safety, Efficacy in Adolescents
FDA Approves First Treatment for Children with Achondroplasia
CVS, Walgreens & Walmart Helped Fuel Opioid Crisis in Ohio Counties
Gilead Boosts Oncology Pipeline With 3 Clinical-Stage Programs
CDC Expands COVID-19 Vaccine Booster Shots To All Americans
US Gov’t Purchases 10M Courses of Pfizer’s COVID-19 Antiviral
Moderna’s mRNA Therapeutic Helps Patients With Heart Failure
FDA Grants Designation For Early-Stage Breast Cancer Blood Test
FDA Expands Pfizer’s COVID-19 Vaccine Booster Authorization
FDA Approves Rare Blood Disease Injection For Adults
Improved Diagnostic Testing Boosts Patient Experience, Study Finds
Pfizer, BioNTech, Zipline Deliver First COVID-19 Vaccines in Ghana
Opdivo Plus Chemotherapy Helps Non-Small Cell Lung Cancer Patients
Pfizer, Biohaven Commercialize Generic Drug For Migraine Attacks
Jardiance Slows Kidney Decline by 40% in Heart Failure Patients
Abbott, ADA Initiative Addresses Diabetes Care Management in POC
J&J Increases Access To Its COVID-19 Vaccine Through COVAX
President Biden Nominates Former FDA Commissioner as Head of FDA
CHMP Recommends Approval Of Roche’s COVID-19 Antibody Combination
GSK’s Daprodustat Effective in Chronic Kidney Disease Patients
Moderna Enters Partnership To Advance Gene Editing Therapeutics
Gilead, Merck Initiate Phase 2 Study for HIV Treatment in Adults
Merck’s COVID-19 Treatment Receives First Authorization in UK
Abbott Increases Clinical Trial Diversity In Medical Research
Pfizer’s COVID-19 Treatment Reduces Hospitalization by 89%
FDA Approves Novartis’ Chronic Myeloid Leukemia Treatment
CDC Recommends Pfizer- BioNTech COVID-19 Vaccine for Children
Feds Purchases More Doses of Lilly’s COVID-19 Antibody Treatment
Moderna Doses the First Participant in Study of CMV mRNA Vaccine
Novartis, Global Heart Hub to Combat Cardiovascular Disease
Roche Launches Genomic Profiling Kit to Boost Oncology Research
FDA Authorizes Thermo Fisher’s COVID-19 New Test Collection Method
Collaboration to Study Antibody Drug, Keytruda in Lung Cancer
Eli Lilly Drug Proves Effective In Adults With Type 2 Diabetes
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Children
NIH, FDA, 15 Orgs Boost Gene Therapy Development for Rare Diseases
FDA Accepts Application for Novartis’ Diabetic Macular Edema Drug
New Pilot to Leverage API, AI for Enhanced Diagnostic Accuracy
Bristol Myers Squibb Reinforces Efficacy of MS Drug, Zeposia
FDA Approves Eli Lilly and Company’s Breast Cancer Treatment
Cerner Leverages Real-World Evidence to Advance Therapies
Two Doses of Moderna’s COVID-19 Vaccine Effective in Children
FDA Approves Expansion of Gilead’s HIV Drug in Pediatric Patients
Pfizer, BioNTech COVID-19 Vaccine Booster Dose 95.6% Effective
CDC Unanimously Recommends J&J, Moderna COVID-19 Vaccine Booster
CVS Health Says Pharmacists Key for Medication Adherence, Access
FDA Authorizes Moderna, J&J Booster COVID-19 Vaccine Dose
FDA Approves Interchangeable Biosimilar for Inflammatory Diseases
FDA Approves First Treatment for Rare Disease Congenital Athymia
FDA Awards $25M in Grants to Clinical Trials Studying Rare Diseases
FDA Recommends Booster Dose of Moderna’s COVID-19 Vaccine
FDA Recommends Authorization For J&J’s COVID-19 Vaccine Booster
Roche Receives Breakthrough Therapy for Alzheimer’s Disease
AstraZeneca’s COVID-19 Antibody Prevents and Treats COVID-19
Merck Enters Into $11.5B Deal to Boost Cardiovascular Pipeline
WHO Recommends Broad Roll-Out of GSK’s Malaria Vaccine For Children
Moderna to Build State-of-the-Art mRNA Facility in Africa
J&J’s Early-Stage Compound Shows Promise Against Dengue Virus
FDA Grants Designation For Daiichi Sankyo’s Breast Cancer Treatment
J&J’s Chief Scientific Officer Paul Stoffels Announces Retirement
ViiV Healthcare Submits FDA Application for HIV Regimen
AstraZeneca Acquires Caelum Biosciences For Rare Disease Antibody
Marketing Strategies to Boost Access to Prescription Medications
J&J Submits Data to FDA to Support COVID-19 Vaccine Booster
FDA Approves Kite’s CAR T-Cell Therapy For Leukemia
Johnson & Johnson Launches Phase 3 Trial of RSV Vaccine in Adults
FDA Approves Amgen’s Repatha for Autosomal Dominant Disease
AstraZeneca Requests FDA EUA for COVID-19 Antibody Combination
Francis Collins Resigns as Director of the NIH After 12 Years
J&J’s Xarelto Evokes Fewer Blood Clots in Patients Than Aspirin
Regeneron’s COVID-19 Antibody Cocktail Helps Hospitalized Patients
Pfizer Submits Data to FDA For COVID-19 Vaccine in Children
Eli Lilly and Company to Drop Insulin Costs 40% in the US
FDA Approves Abbott’s Epic Plus for Aortic Valve Disease
Pfizer Launches Trial of COVID-19 Treatment for Post-Exposure
AstraZeneca Invests in VaxEquity for saRNA Therapeutics Platform
Improving Adult Vaccination Rates, Health Outcomes Globally
Roche’s Tecentriq Benefits Non-Small Cell Lung Cancer Patients
SAS, UNC-Chapel Hill to Transform Antiviral Drug Development
Thermo Fisher Launches System to Scale Gene Therapy Workflows
COVID-19 Treatment Remdesivir Reduces Hospitalizations by 87%
AbbVie Helps to Advance Gene Therapy for Chronic Retinal Diseases
FDA Authorizes Booster Dose of Pfizer, BioNTech COVID-19 Vaccine
FDA Approves First Biosimilar to Treat Macular Degeneration
Thermo Fisher Launches Enzyme Analyzers for Assay Applications
Second Dose of J&J’s COVID-19 Vaccine 94% Effective
J&J’s Ebola Vaccine Generates Robust Antibody Responses
FDA Grants Breakthrough Designation for Eli Lilly’s Diabetes Drug
Pfizer, BioNTech COVID-19 Vaccine Effective in Pediatric Patients
Providers Hopeful of Immunotherapy to Treat Early-Stage Cancer
Pharma Companies Challenge Federal Plans to Lower Drug Pricing
Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine
FDA Accepts Novartis BLA for Monoclonal Antibody in ESCC
Roche Acquires TIB Molbiol to Boost Molecular Diagnostics Profile
Thermo Fisher Launches Portfolio to Advance Quantitative Analysis
Sanofi Inks $1.9B Pharma Acquisition Deal with Kadmon Holdings
Pfizer Initiates Phase 3 Clinical Trial of RSV Vaccine in Adults
Medidata, Labcorp Collaborate to Boost Digital Biomarker Discovery
Moderna, ILCM to Develop mRNA Therapeutic for Ultra-Rare Disease
Biden Administration Unveils Plan to Lower Prescription Drug Prices
3 Use Cases for Real World Evidence in Pharma Drug Development
Eli Lilly’s Jardiance Reduces Death for Heart Failure Patients
FDA Approves Johnson & Johnson’s Schizophrenia Injectable
Novartis Boosts Access to Cholesterol-Lowering RNA Therapy
Premier, Top Health Systems Acquire Exela to Combat Drug Shortages
Thermo Fisher, AstraZeneca to Develop NGS-Based Targeted Therapies
Moderna Submits Initial Data to FDA for COVID-19 Vaccine Booster
Cardiovascular Disease Clinical Trials Still Lack Diversity
Eli Lilly, Lycia Collaborate to Discover Targeted Drug Candidates
Top Manufacturers of Most Prescribed Drugs in Medicare
AMA, APhA, ASHP Call for Immediate End to Ivermectin for COVID-19
Pfizer, BioNTech COVID-19 Vaccine Expands to Latin America
FDA Approves Vivistim System for Chronic Ischemic Stroke
Merck’s Pneumococcal Vaccine Meets Key Endpoints in Phase 3 Trial
COVID-19 Convalescent Plasma Fails to Halt Disease Progression
J&J COVID-19 Vaccine Booster Elicits Strong Antibody Responses
Novartis Cancer Treatment Fails in Phase 3 Clinical Trial
Role of Digital Therapeutics in Chronic Disease Management
FDA Accept Johnson & Johnson’s Expanded Indication for Xarelto
FDA Accepts Biologics License Application for BMS aGvHD Therapy
Pfizer Enters Acquisition Deal for Immuno-Therapeutics Pipeline
AstraZeneca’s COVID-19 Antibody 77% Effective in Phase 3 Trial
FDA Grants Accelerated Approval to GSK’s dMMR Antibody Drug
CureVac’s Second COVID-19 Vaccine Elicits Improved Immune Response
Novartis’ Diabetic Macular Edema Drug Successful in 2 Trials
Pfizer-BioNTech COVID-19 Vaccine Gets Full FDA Approval
GoodRx, Boehringer Increase Affordable Drug Access for Patients
New CEO to Take Over for Gorsky at Johnson & Johnson
FDA Approves Abbott’s Atrial Fibrillation Device to Prevent Stroke
Moderna Doses First Patient in Study of mRNA Therapeutic for MMA
FDA Authorizes Thermo Fisher’s PCR-Based COVID-19 Test Kits
FDA Approves New Indication for Chronic Disease Treatment
UPMC Expands Access to Monoclonal COVID-19 Antibody Treatments
WHO Launches Next Trial Phase to Test COVID-19 Drugs in Patients
NCQA Program Supports Best Practices in Specialty Pharmacy
FDA OKs 3rd COVID-19 Vaccine Dose for the Immunocompromised
Most Important FDA Novel Drug Approvals of 2021, So Far
Novavax’s COVID-19 Vaccine Booster Neutralizing Antibody Levels
FDA Accepts Merck’s Keytruda Application for Endometrial Carcinoma
Bayer Enters Pharma Acquisition Deal for Undruggable Targets
Kite, Appia Bio to Research Allogeneic Cell Therapies for Cancer
Moderna Doses First Patient in Study of Autoimmune mRNA Candidate
FDA Grants Fast Track to Moderna’s mRNA RSV Vaccine for Adults
FDA Broadens Authorization for Eli Lilly’s COVID-19 Treatment
51% of Retail Pharmacy Customers Used Wellness Services in 2020-21
FDA Approves GSK’s Antibody for Chronic Disease Management
Sanofi, Translate Enter Pharma Acquisition Deal for mRNA Vaccines
FDA Expands Authorization of Regeneron’s COVID-19 Antibody Cocktail
Roche Gets FDA Priority Review for Non-Small Cell Lung Cancer Drug
Eli Lilly, Kumquat to Discover Drug Candidates for Tumors
Amgen Enters Pharma Acquisition Deal to Develop New Biologics
AstraZeneca, Regeneron to Develop Drug Candidates to Treat Obesity
UIC Awarded $6M to Test COVID-19 Drug Candidate For Lung Damage
Biogen’s Alzheimer’s Disease Drug Safe, Effective in Trial
FDA Approves Mylan’s Interchangeable Biosimilar Insulin Product
AstraZeneca’s COVID-19 Vaccine 82% Effective Against Variants
AbbVie, Calico Extend Partnership for Age-Related Disease Therapies
FDA Approves Merck’s Keytruda for Triple-Negative Breast Cancer
FDA Approves Merck’s Keytruda Treatment for Endometrial Carcinoma
Bristol Myers Squibb Pulls Immunotherapy Opdivo from US Market
Pharmaceutical Supply Chain Needs Reform for Transparency, Access
Pfizer, Arvinas to Develop Protein Degrader for Breast Cancer
FDA Grants Breakthrough Therapy for Roche’s MDS Treatment
High-Dose Buprenorphine Helped Untreated Opioid Use Disorder
Lilly Enters Collaboration for Phase 3 Trial of Alzheimer’s Drug
FDA Approves Sanofi’s All-Oral Treatment for Sleeping Sickness
Pfizer Completes Trial Enrollment for Lyme Disease Vaccine
BioNTech to Acquire Kite’s TCR Platform for Cell Therapy Pipeline
Eli Lilly Enters Pharma Acquisition Deal for Diabetes Treatment
J&J COVID-19 Vaccine Elicits Antibody Responses Against Variants
Biogen, InnoCare Pharma Partner for Multiple Sclerosis Treatment
FDA Authorizes Ortho Clinical’s COVID-19 Antibody Test
St. Jude Medical to Pay $27M to Resolve Healthcare Fraud Allegations
Study Finds Major Medicare Overspending Generic Prescription Drugs
Moderna Doses First Patient in Study of Flu mRNA Vaccine Candidate
Medicare Prescription Drug Prices Doubled Since 2005
Gavi Signs Agreement for Sinopharm, Sinovac COVID-19 Vaccine Doses
FDA Updates J&J COVID-19 Vaccine Label to Include Rare Disorder
FDA Seeks Investigation Over Approval of Alzheimer’s Drug, Aduhelm
Pfizer, AbbVie, Biogen Launch Resource for Genetic Variants
Thermo Fisher, UC Davis Launch Center of Excellence for Metabolomics
FDA: Aduhelm Only to Be Given to Early-Stage Alzheimer’s Patients
Improving Health Equity Across the Pharmaceutical Industry
FDA Issues Complete Response Letter for Type 1 Diabetes Antibody
Merck Gains FDA Approval for Expanded Indication of Keytruda
J&J COVID-19 Vaccine Neutralizes Activity Against Delta Variant
GSK, Alector to Develop Antibodies for Neurodegenerative Diseases
AstraZeneca’s Antibody Favorable in RSV in Phase 2/3 Trial
FDA Approves Key Component for Common Childhood Cancer Treatment
Pfizer Halts Distribution of Smoking Cessation Drug, Chantix
Gilead Submits New Drug Application to FDA for HIV Treatment
DTC Pharmaceutical Marketing Linked $324B in Medicare Drug Spending
Higher Dose of Ozempic Further Advances Diabetes Care Management
Walmart Analog Insulin to Streamline Diabetes Care Management
Moderna’s COVID-19 Vaccine Elicits Activity Against All Variants
Kite’s T-Cell Therapy 60% Effective Against Large B-Cell Lymphoma
ViiV Healthcare, Halozyme to Develop Long-Acting HIV Treatment
US Pauses All Distribution of Eli Lilly’s COVID-19 Antibody
uniQure Inks Gene Therapy Acquisition Deal with Corlieve Therapeutics
Lilly’s Drug Receives Breakthrough Therapy for Alzheimer’s Disease
FDA Gives EUA for Genentech’s Actemra for COVID-19 Hospitalizations
Health Officials Say Myocarditis After COVID-19 Vaccination “Rare”
FDA Approves Boehringer’s Pediatric Oral Blood Thinner
Orphazyme Receives FDA Complete Response Letter for Rare Disease
GoodRx Users Save an Average $30B on Prescription Drug Costs
Aduhelm to Boost Prescription Drug Spending Over $73B by 2028
Gilead’s Remdesivir Lowers Risk of Mortality in COVID-19 Patients
Bristol Myers Squibb to Co-Develop Eisai’s Antibody Drug Conjugate
CRISPR Therapeutics, Capsida Collaborate to Develop Gene Therapies
Biden Invests Over $3B to Boost COVID-19 Antiviral Development
Thermo Fisher Uses Next-Generation Sequencing to ID COVID Variants
Pfizer’s Drug Helps COVID-19 Patients Hospitalized with Pneumonia
Congress Reintroduces PASTEUR Act to Combat Antimicrobial Resistance
Regeneron’s COVID-19 Antibody Cocktail Reduces Death by 20%
FDA Guidance Addresses Patient Outcomes in Cancer Clinical Trials
Novavax COVID-19 Vaccine 100% Effective in Phase 3 Clinical Trial
FDA Approves Novo Nordisk’s Obesity Drug Wegovy
3 FDA Committee Members Resign Over Alzheimer’s Drug Approval
FDA Boosts Johnson & Johnson’s COVID-19 Vaccine for Export
US Acquires 1.7B Courses of Merck’s COVID-19 Treatment
Pfizer, BioNTech Give US 500M Doses of COVID-19 Vaccine
Understanding Basic Principles of Pharmaceutical Drug Discovery
Biden Pushes Policy Changes to Protect Pharmaceutical Supply Chain
Breaking Down the Approval of Biogen’s Aducanumab
Abbott, Walgreens Increase Rapid COVID-19 Testing in Pennsylvania
Bayer Inks Pharma Acquisition Deal to Advance Cancer Therapies
6-in-1 Pediatric Vaccine from Merck, Sanofi Available Across US
FDA Greenlights Biogen Alzheimer’s Drug Aducanumab Amidst Debate
Prescription Drug Spending Expected to Reach $400B in 2025
EU Approves AstraZeneca’s Non-Small Cell Lung Cancer Drug
Moderna, UNICEF to Supply COVID-19 Vaccine on Behalf of COVAX
FDA Approves First Targeted Non-Small Cell Lung Cancer Therapy
Janssen’s Teclistamab Gets FDA Breakthrough Therapy Designation
Moderna Initiates Rolling Submission for COVID-19 Vaccine
CMS Proposes Delay of Medicaid Value-Based Payment Requirements
Moderna, Aldevron Expand Partnership for mRNA COVID-19 Vaccine
8 Companies Claim CVS Health Overcharged for Prescription Drugs
Emergency Use Authorization Granted for GSK-Vir COVID-19 Antibody
Prescribers Switch to Remdesivir for COVID-19 Treatment
J&J’s Biologic Therapy Stelara Helps Crohn’s, Ulcerative Colitis
Japan Grants AstraZeneca’s COVID-19 Vaccine Emergency Use
Moderna’s mRNA COVID-19 Vaccine 100% Effective in Adolescents
FDA Approves Janssen’s Targeted Non-Small Cell Lung Cancer Therapy
GSK-Medicago COVID-19 Vaccine Elicits High Antibody Responses
Thermo Fisher, UCSF Boost Manufacturing of Cell-Based Therapies
GSK, Sanofi COVID-19 Vaccine Elicits Strong Antibody Response
Pharmaceutical Supply Chain Cybersecurity Risk Tops $31M Annually
FDA Guidance Addresses Master Protocols for COVID-19 Drugs
Biogen’s XLRP Gene Therapy Fails in Phase 2/3 Clinical Trial
Abbott’s Navitor for Severe Aortic Stenosis Receives CE Mark
Merck’s Keytruda Helps Patients with High-Risk Breast Cancer
Top mRNA COVID-19 Vaccines 94% Effective, New CDC Data Shows
Moderna Provides 25M Doses of COVID-19 Vaccine to Australia
Biogen, Capsigen Create AAV Capsids to Deliver Gene Therapies
Eli Lilly Taps saRNA Research Tech from MiNA for Drug Discovery
Eli Lilly Takes on Digital Diabetes Care Management
EMA Assesses Blood Clots, Other Side Effects of COVID-19 Vaccines
Pfizer, BioNTech Seek Full FDA Approval for COVID-19 Vaccine
Pfizer COVID-19 Vaccine Can be Used in Adolescents, FDA Says
Out-of-Pocket Costs for Brand-Name Medications Increased 15%
NHS Rolls Out 3D Imaging Technology for Heart Disease Diagnosis
MedRhythm Begins Trial to Study Digital Therapeutics for Stroke
Biden Administration Backs Waiver of COVID-19 Intellectual Property
CVS Caremark Prescription Drug Trend Rose to 2.9% in 2020
CVS Goes to Workplace Vaccination Sites to Boost Access
Gavi Secures 500M Doses of Moderna’s COVID-19 Vaccine for COVAX
FDA Greenlights AstraZeneca’s Farxiga for Chronic Kidney Disease
Moderna Increases Global 2022 COVID-19 Vaccine Capacity to 3B
Northwell, Pear Therapeutics Provide New Opioid Treatment Options
Pfizer Acquires Amplyx to Grow Anti-Infective Therapies Pipeline
AI in the Pharma Industry: Current Uses, Best Cases, Digital Future
Abbott Launches Artificial Intelligence-Powered Imaging Platform
Few Drugs Make Half of Medicare Prescription Drug Spending
FDA Completes Review of J&J Vaccine Manufacturing Facility
Early COVID-19 Treatments Elicited No Real Benefits in Patients
Health2047 to Improve Clinical Trial Access with New Venture
COVID-19 Mortality Dropped as Drug Therapies Emerged
FDA, CDC Lift Pause of Johnson & Johnson’s COVID-19 Vaccine
Powering In Silico Pharmaceutical Innovation with Robust IT
Rollout of Johnson & Johnson’s COVID-19 Vaccine Resumes in Europe
Biogen Releases Update on Multiple Sclerosis Therapies Profile
FDA Rescinds EUA for Eli Lilly’s Monoclonal COVID-19 Antibody
FDA Approves Opdivo as First Immunotherapy for Gastric Cancer
FDA Issues Guidance on Remote Interactive Evaluations During COVID
Eli Lilly Asks FDA to Revoke the EUA for COVID-19 Antibody Drug
Trial Updates from Moderna’s mRNA, RSV Vaccine Candidates
China Approves AstraZeneca’s Non-Small Cell Lung Cancer Drug
Gilead Stops Phase 3 Remdesivir Trial in COVID-19 Patients
Roche’s COVID-19 Antibody Cocktail Reduces Symptoms by 81%
Medical AI Device Evaluation Process Could Mask Vulnerabilities
FDA Approves Marketing of AI Medical Device to Detect Colon Cancer
FDA, CDC Pauses J&J COVID-19 Vaccine Due To Rare Blood Clot Cases
Biotech Company Launches Medical Device for Blood Transfusions
Hologic Acquires Molecular Diagnostic Test Developer for $795M
Gilead’s Trodelvy Gets FDA Nod for Breast Cancer Treatment
Data Reveals High Vaccine Efficacy for Moderna, Pfizer Doses
European Countries Suspend Use of AstraZeneca’s COVID-19 Vaccine
FTC Challenges $7.1B Illumina-Grail Pharma Acquisition Deal
AstraZeneca Eyes Medical Devices for Chronic Disease Management
Biden Focuses on Opioids in Prescription Drug Policy Priorities
J&J Takes Over Vaccine Production at Plant That Spoiled 15M Doses
FDA Makes Revisions to Moderna’s COVID-19 Vaccine Authorization
NIH Launches COVID Variant Trial; Pfizer Releases New Data
TCR2 Establishes Cell Therapy Manufacturing Facility in MD
FDA Requests More Data from Merck on Keytruda for Breast Cancer
FDA Approves First Cell-Based Gene Therapy for Multiple Myeloma
Pfizer-BioNTech COVID-19 Vaccine 100% Effective in Adolescents
Real-World Evidence Confirms Efficiency of mRNA COVID-19 Vaccines
Children Produce More COVID-19 Antibodies, Study Finds
Moderna Studies COVID-19 Vaccine Candidate in Pediatric Population
How to Establish an Antibiotic Stewardship Program
COVID-19 Antigen Tests Prove More Accurate in Symptomatic Patients
AstraZeneca COVID-19 Vaccine 76% Effective in Phase 3 Trial
FDA Grants First Marketing Approval for COVID-19 Diagnostic Test
Eli Lilly’s COVID-19 Antibody Reduces Hospitalizations by 87%
COVID-19 Hospitalizations Spark Overuse of Antibiotic Concerns
FTC Takes New Approach to Analyzing Pharmaceutical Mergers
GSK COVID-19 Antibody Elicits 85% Drop in Hospitalizations, Deaths
Real-World Evidence Confirms Pfizer COVID-19 Vaccine Effectiveness
Supporting Digital Innovation in Radiology, Imaging
UK and EU Reaffirm Safety of AstraZeneca’s COVID-19 Vaccine
Eli Lilly, Biolojic to Develop Antibody Therapies for Diabetes
Amgen Acquires Five Prime in $1.9B Pharma Acquisition Deal
PhRMA Seeks IP Protections for COVID-19 Vaccine Developments
FDA Authorizes Sequencing-Based COVID-19 Diagnostic Test
RNA-Based Vaccine May Fully Immunize Against Malaria
CVS Works to Improve Drug Affordability, Accessibility
FDA Authorizes First At-Home Molecular COVID-19 Diagnostic Test
GE Gets $41M to Accelerate Vaccine Manufacturing, Distribution
US Buys More Doses of Eli Lilly’s COVID-19 Antibody Therapy
Merck to Manufacture Johnson & Johnson COVID-19 Vaccine for US
AstraZeneca Furthers COVID-19 Vaccine Rollout Through COVAX
CDC Advisors Recommend Johnson & Johnson COVID-19 Vaccine
GSK Antibody Helps Combat Respiratory Failure from COVID-19
Moderna Ships Doses of Variant-Specific COVID-19 Vaccine to NIH
Best Practices for Addressing Diversity in Clinical Trials
Study Finds Diversity in Clinical Trials Still Lacking
Pfizer, BioNTech Submit COVID-19 Vaccine Stability Data to FDA
Additional Moderna Investments to Boost COVID-19 Vaccine Output
Eli Lilly to Codevelop Inhibitors for Neurodegenerative Diseases
Pfizer to Study COVID-19 Vaccine in Pregnant Women
FDA Issues New Guidance for COVID-19 Vaccine Developers
FDA Authorizes Johnson & Johnson’s Single-Dose COVID-19 Vaccine
bluebird bio Suspends Studies of Sickle Cell Disease Gene Therapy
FDA Analysis Finds J&J’s COVID-19 Vaccine Safe, Effective
Thermo Fisher Launches 2D-Liquid Chromatography System
GSK, VIR Expand Agreement to Develop Novel Therapies for Influenza
GSK Doses First Patient in Phase 3 Study of RSV Vaccine Candidate
FDA Approves G1’s Cosela to Prevent Damage from Chemotherapy
HHS, DoD Buy 100M More Doses of Moderna, Pfizer COVID-19 Vaccines
Speeding Innovation in Genomics with Modern-Day Infrastructure
HHS Releases New Actions to Expand COVID-19 Testing Across the US
GoodRx Reports Largest Uptick in Prescription Drug Prices in Years
WHO Grants Emergency Use to AstraZeneca’s COVID-19 Vaccine
AstraZeneca, Biologika to Increase Output of COVID-19 Vaccine
Eli Lilly Enhances Local Access to COVID-19 Antibody Therapies
AbbVie, Caribou Biosciences to Develop CAR-T Cell Therapies
Pfizer Boosts Access to Cancer Treatments in Developing Countries
Pharmaceutical Supply Chain Increases Outpatient Drug Costs
CVS Health Boosts Access to COVID-19 Vaccines Across 11 States
FDA Approves Bristol Meyers Squibb CAR T Cell Therapy for Lymphoma
Siemens Healthineers Receives CE Mark for COVID-19 Antigen Test
Bristol Myers Squibb Gives $53M to Support Cancer Immunotherapies
FDA Approves Eli Lilly’s Combination COVID-19 Antibody Treatment
Roche to Launch Self-Administered COVID-19 Antigen Test
GSK, CureVac to Develop Next Generation mRNA COVID-19 Vaccines
PhRMA Challenges 340B Drug Pricing Program ADR Rule
HHS Expands Workforce Authorized to Administer COVID-19 Vaccines
Virtual Clinical Trial Kicks Off in NY to Study COVID-19 Therapy
AstraZeneca’s COVID-19 Vaccine 82% Effective After Second Dose
Top Pharma Companies Boost Access to Drug Development Pipeline
Eli Lilly’s COVID-19 Antibodies Reduce Hospitalizations by 70%
US Prescription Drug Prices 256% Higher Than Other Countries
First Patient Dosed in Trial of Two Separate COVID-19 Therapies
COVAX Purchases 40M Doses of Pfizer, BioNTech’s COVID-19 Vaccine
GSK, Novartis to Study Genetic Diversity for Drug Development
J&J’s COVID-19 Vaccine 66% Effective in Moderate, Severe Cases
Novavax COVID-19 Vaccine 89% Effective Against UK COVID-19 Strain
Biden’s Executive Order on Expanding Access to COVID-19 Therapies
Moderna Doses First Patient in Japanese Study of COVID-19 Vaccine
FDA Authorizes First Long-Acting Injectable for HIV Treatment
Thermo Fisher Inks $450M Deal to Acquire Mesa Biotech
Merck Terminates Development of COVID-19 Vaccine Candidates
Pfizer’s COVID-19 Vaccine Elicits Antibodies Against UK Strain
US to Remain WHO Member, Join Global COVID-19 Vaccine Program
Gilead, Vir Biotechnology to Evaluate Novel Therapies for HBV
COVID-19 Vaccine Dominates 2021 Pharmaceutical Industry Trends
Biden Executive Order Details New COVID-19 Response Plan
Janet Woodcock Acting FDA Commissioner After Hanh’s Departure
Experts Torn Over Half-Dosing Moderna, Pfizer COVID-19 Vaccines
Eli Lilly, Merus to Develop T-Cell Bispecific Antibody Therapies
HHS Expands Access to Buprenorphine for Opioid Use Disorder
Second COVID-19 Antibody from Vir, GSK Enters Phase 1b Trial
Switzerland Authorizes Moderna’s mRNA COVID-19 Vaccine
How Technology is Helping One Health System Distribute COVID-19 Vaccines
COVID-19, Vaccine Development Trends at JPM21
HHS Buys 1.25M More Doses of Regeneron’s COVID-19 Antibody Cocktail
Pfizer Invests $120M to Advance Biotechnology Innovation
Kaiser to Track Serious Adverse Events From COVID-19 Vaccination
HHS Distributes $22B to States for COVID-19 Testing, Vaccinations
NIH Initiates Trial to Evaluate COVID-19 Antibody Therapy
First Patient Treated in Study of Biogen’s Rare Disease Drug
EU Grants Emergency Use for Moderna’s mRNA COVID-19 Vaccine
Pfizer Kicks Off Phase 3 Trial for Rare Disease Gene Therapy
Kite, Oxford BioTherapeutics Partner to Research Cell Therapies
AstraZeneca’s COVID-19 Vaccine Gains Emergency Use in 6 Countries
Fujifilm to Invest $40M in Viral Vector Manufacturing Facility
FDA Approves First Generic Drug for Severe Hypoglycemia
FDA Warns Against Half-Dosing Pfizer, Moderna COVID-19 Vaccines
Moderna Ups COVID-19 Vaccine Manufacturing Estimate to 600M in 2021
UK Authorizes Emergency Use of AstraZeneca’s COVID-19 Vaccine
EU to Acquire Extra 100M Doses of Pfizer’s COVID-19 Vaccine
HHS Unveils 3-Part Plan for Supporting COVID-19 Testing Efforts